Skip to main content
. 2021 Oct 16;9(29):8694–8701. doi: 10.12998/wjcc.v9.i29.8694

Table 4.

Comparison of the incidence of adverse reactions between the two groups, n (%)

Group
n
Pain at injection site
Skin itch
Vomiting and nausea
Gastrointestinal reaction
Total incidence rate
Study 37 1 (2.50) 0 (0.00) 2 (5.00) 0 (0.00) 3 (7.50)
Control 37 1 (2.50) 2 (5.00) 1 (2.50) 1 (2.50) 5 (12.50)
χ2 0.140
P value 0.708